CNS Summit 2022
Meet with Cognivia at the CNS Summit 2022
Going to the CNS Summit in Boca Raton, Florida from November 17-20? We’d love to connect with you about what’s next for the life sciences industry.
The CNS Summit brings together people that are passionate about changing care and changing lives – and we’re excited to join the conversation.
CEO Dominique Demolle, PhD, and CSO Alvaro Pereira will be there, exhibiting Cognivia’s novel solutions in the clinical trials space and meeting with industry peers.
As we all work towards a common goal, it’s important that we learn from each other. We hope to see you there!
Let’s meet to discuss how we can put new technologies and science together to improve clinical trials and bring important therapies to patients, faster.
Set Up Meeting
Cognivia is an innovator of analytical tools to optimize and accelerate the clinical development of new medicines. The privately held company was founded in 2013 by longtime colleagues with decades of experience in the pharmaceutical industry who set out to tackle some of the most challenging issues that prevent drugs from reaching the marketplace. Cognivia helps lessen risk and increase clinical trial success. It can help reduce the variability of study data by 30 percent, which directly translates into increased study power and reduced risk of trial failure. This can further lead to fewer patients needed in a study, equating to less cost and time.
The company offers Placebell, a solution that improved clinical trial assay sensitivity by characterizing and managing the individual placebo response in a variety of disease states where the placebo effect masks the true efficacy of potentially important therapies.